London South East were delighted to welcome Incanthera to our April Investor Webinar (6.04.2021), where Chairman Tim McCarthy and CEO Dr Simon Ward presented and took questions. Watch the full interview here.

Less Ads, More Data, More Tools Register for FREE

Cambridge Cognition shares up 21% after new GBP500,000 contract win

Thu, 8th Apr 2021 11:56

(Alliance News) - Cambridge Cognition Holdings PLC has won a GBP500,000 contract with a pharmaceutical firm to provide cognitive assessments in a clinical trial, it said on Thursday.

Shares surged 21% to 119.00 pence around midday in London.

Cambridge Cognition develops and markets digital solutions to assess brain health and has said most of the contract revenue is expected to be recognised in 2021.

The pandemic has accelerated interest in virtual or decentralised clinical trials, with more assessments being planned at home and therefore out of the clinic setting.

Cambridge Cognition Chief Executive Officer Matthew Stork said: "We are delighted to have secured this contract and to be supporting another major pharmaceutical company to assess cognition in patients' homes."

"This is a trend that we expect to continue and will therefore provide more growth opportunities for Cambridge Cognition in the future."

The clinical trial aims to assess patients' cognition from their homes and is sponsored by a "leading" pharmaceutical company.

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News

Cambridge Cognition wins at-home clinical trial contract

(Sharecast News) - Brain health technology company Cambridge Cognition has won a contract with a new pharmaceutical client to provide cognitive assessments in an at-home clinical trial, it announced on Thursday.

8 Apr 21 12:48

Cambridge Cognition shares up 21% after new GBP500,000 contract win

Cambridge Cognition shares up 21% after new GBP500,000 contract win

8 Apr 21 11:56

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

8 Apr 21 11:24

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

30 Mar 21 16:03

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.